The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHummingbird Regulatory News (HUM)

Share Price Information for Hummingbird (HUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.25
Bid: 8.00
Ask: 8.50
Change: 1.10 (15.71%)
Spread: 0.50 (6.25%)
Open: 7.25
High: 8.10
Low: 7.25
Prev. Close: 7.00
HUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placement Update, Open Offer & Notice of GM

21 Dec 2023 07:00

RNS Number : 5962X
Hummingbird Resources PLC
21 December 2023
 

Hummingbird Resources plc / Ticker: HUM / Index: AIM / Sector: Mining

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA, THE UNITED STATES (OR TO ANY U.S. PERSON), CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION EU NO. 596/2014, AS RETAINED AND APPLICABLE IN THE UK PURSUANT TO SECTION 3 OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

21 December 2023

Hummingbird Resources plc

("Hummingbird", "Group" or the "Company")

Placement Update, Open Offer & Notice of General Meeting

Further to the Company's announcement on the 7 December 2023 of a placement of up to US$30 million, including a part conditional investment by the Company's largest shareholder and strategic investor CIG SA ("CIG") (the "CIG Subscription") of US$25 million, the Company is pleased to confirm an additional conditional subscription of c.US$2.0 million (c.£1.6 million) (the "Second Tranche Subscription") from new shareholders that includes US$1.0 million from Ernie Nutter a Non-Executive Director of the Company. Further, the Company is offering an open offer to its existing shareholders to raise up to c.US$5.0 million (£4.0 million) (the "Open Offer").

The CIG Subscription, the Subscription (including both the First Tranche Subscription and the Second Tranche Subscription) and the Open Offer (together the "Placement"), assuming full take up under the Open Offer, and all shareholder resolutions are passed to approve the Placement, would result in total gross proceeds for the Company of c.US$32.7 million. The Placement will be used to accelerate the Company's growth strategy, increase exploration, and strengthen its balance sheet to provide capital support for the Group's operations.

The shareholder circular containing full details of the Placement, including details of how qualifying shareholders can participate in the Open Offer (the "Circular"), will be published today, together with a Notice of General Meeting to be held at 13:00 GMT on 10 January 2024, setting out the shareholder approvals required to complete the Placement, and instructions on how to vote. The Circular and Notice of General Meeting will be sent to Shareholders today and available on the Company's website shortly.

Highlights of the Strategic Investment and Placement Update & Notice of General Meeting

· The CIG Subscription, as previously announced, of US$25 million, is made up of two investment tranches, the first of which has completed, with the second tranche of US$20.2 million being subject to shareholder approval (the "CIG Second Tranche Subscription"). CIG currently holds 29.9% of the Company's issued share capital, and assuming the full take up under the Open Offer and completion of the Placement will hold 40.2% of the Company's enlarged share capital.

· The Second Tranche Subscription has conditionally raised an additional c.US$2.0 million (c.£1.6 million), also subject to shareholder approval.

· An Open Offer to qualifying shareholders to raise up to an additional c.US$5.0 million (£4.0 million), also subject to shareholder approval. CIG, together with the participant in the First Tranche Subscription, have agreed not to take up their entitlement in the Open Offer.

· All new ordinary shares issued in connection with the Placement will be issued at a price of 11.2625 pence per new Ordinary Share.

· The CIG Second Tranche Subscription, the Second Tranche Subscription and the Open Offer are subject to approval by Shareholders at a General Meeting to be held at 13:00 GMT on 10 January 2024, the details of which are set out in the Circular, an extract from which is detailed below. The Second Tranche Subscription and the Open Offer are each conditional on the approval by shareholders of the CIG Second Tranche Subscription.

All US$:£ amounts used in this announcement have been calculated based on an exchange rate of US$0.7937.

Extract from the Circular - Part 1 - Letter from the Chairman (selected paragraphs)

Introduction

On 7 December, the Company announced that it is undertaking an equity placement of up to approximately US$30 million, subject to, inter alia, shareholder approval, comprised of a partially conditional US$25 million investment by CIG and up to US$5 million from other investors. The Placement is split across two tranches with the following confirmed figures in respect of the second tranche:

· A firm first tranche of US$5.5 million, made pursuant to the 2023 Authorities, which involved the issue of the CIG First Tranche Shares (which has resulted in a CIG holding of 29.999 per cent. in the Company, as at the Latest Practicable Date) and the First Tranche Subscription Shares and;

· A conditional second tranche, subject to, inter alia, shareholder approval, of approximately US$22.2 million, which involves the issue of the CIG Second Tranche Shares (which, dependant on the level of acceptances under of the Open Offer will result in CIG establishing a holding of between 40.2 per cent. and 42.0 per cent. in the Company) and the issue of the Second Tranche Subscription Shares. As part of the Second Tranche Subscription, Ernie Nutter, director of the Company, is conditionally subscribing for 6,993,780 Subscription Shares.

In addition, the Company is offering Shareholders the opportunity to subscribe for new Ordinary Shares at the Issue Price through the Open Offer, details of which are set out in this document.

The Issue Price is 11.2625 pence per new Ordinary Share.

CIG is subscribing for the CIG Second Tranche Shares subject to, inter alia, the granting of a Rule 9 Panel Waiver, to be approved by the Rule 9 Waiver Resolution, of the obligations that would otherwise fall upon CIG pursuant to Rule 9 of The Takeover Code to make an offer for the entire issued share capital of the Company as a result of the potential issue of the CIG Second Tranche Shares to CIG, which will lead to its interest in the Company increasing to over 30 per cent, to between 40.2 per cent. and 42.0 per cent. dependent on the level of acceptances for the Open Offer. Further details on the Rule 9 Waiver are set out in Part 5 of this document.

The Panel has agreed to waive the obligation on CIG to make a general offer that would otherwise arise as referred to above, subject to the approval by the Independent Shareholders of the Rule 9 Waiver Resolution on a poll. Conditional upon the Resolutions being passed at the General Meeting it is expected that the Second Tranche Subscription Shares and CIG Second Tranche Shares will be admitted to trading on AIM on 11 January 2024.

The Open Offer provides Qualifying Shareholders (other than CIG and the subscriber under the First Tranche Subscription) with an opportunity to participate in the proposed issue of the new Ordinary Shares at the Issue Price.

The Company considers it important that, where reasonably practicable, Shareholders have an opportunity to participate in its equity placements. To that end, the Board is providing Qualifying Shareholders with the opportunity to subscribe for the Open Offer Shares under the Open Offer at the Issue Price. In connection with the Open Offer, the Company will allot (at the Board's discretion and conditional on Admission) up to 35,516,679 Open Offer Shares and will make an announcement in due course once the total number of Open Offer Shares subscribed for is known. The aggregate maximum subscription under the Open Offer is capped at £4 million and so will be exempt from the requirement to publish a prospectus pursuant to the Prospectus Rules and/or the Prospectus Regulation Rules.

The Company has called the General Meeting inter alia in order to put to Shareholders the resolutions required to grant (i) the authority to issue and allot the CIG Second Tranche Shares, the Second Tranche Subscription Shares and the Open Offer Shares and (ii) approve the Rule 9 Panel Waiver. If the Resolutions are not approved the issue of the CIG Second Tranche Shares, the Second Tranche Subscription Shares and the Open Offer Shares will not proceed and the Company will not receive any funds from the associated issue of these new Ordinary Shares. If the Rule 9 Waiver Resolution is not approved, but the other Resolutions are approved, the Second Tranche Subscription and the Open Offer, which are conditional on the completion of the CIG Second Tranche Subscription will not proceed and the CIG Second Tranche Subscription will not proceed.

Information on the Placement and Open Offer more generally is set out in this Part 1 of this document.

Issue Price

The Issue Price represents approximately a 2 per cent premium to volume weighted average price of the Ordinary Shares for the 30 day period ending on 6 December 2023, being the last practicable day prior to the announcement of, inter alia, the CIG Subscription.

Use Of Funds 

The proceeds of the Placement and the Open Offer (assuming that the Open Offer is fully subscribed), will be US$32.7 million (approximately £26.0 million). The Company will allocate the net proceeds to strengthen the balance sheet of the business and advance multiple growth initiatives as part of the Company's growth strategy. These initiatives encompass exploration activities at both the Yanfolila and Kouroussa Gold Mines, as well as maximising the value of the Dugbe Gold Project.

Hummingbird intends to utilise the proceeds of the Placement and Open Offer as follows:

· Exploration Activities: c.US$5 million of the funds will be directed towards increased exploration activities at the Yanfolila and Kouroussa Gold Mines. The Company's exploration team has developed a comprehensive exploration plan from FY-2024 onwards, focused on high-probability targets aimed at increasing Resources to Reserves for the Group, thereby extending the Life of Mine at both operating assets.

· Dugbe Gold Project Advancement: c.US$2 million of the proceeds will be dedicated to progressing the Dugbe Gold Project in Liberia, bringing this highly valuable asset closer to production. The funds will be used to optimise the 2022 Definitive Feasibility Study through FY-2024 and further progress the Project. Hummingbird and Pasofino Gold Limited have identified several opportunities to maximise the value of Dugbe and reduce the overall project capex profile, including the optimisation of power usage, improvements to the metallurgical recovery rates and additional exploration activities.

· Balance Sheet Strengthening: The remainder of the proceeds will be used to strengthen the Company's balance sheet through deleveraging and operational initiatives. The funds will be allocated to provide additional capital support for the Group as it completes operational initiatives at Yanfolila including, the Komana East Underground operation, and the ramp up of Kouroussa to commercial production in early FY-2024, as well as supporting the deleveraging of the balance sheet.

The New Ordinary Shares will, when issued, rank pari passu in all respects with each other and the Existing Ordinary Shares, including the right to receive dividends and other distributions declared following Admission.

CIG Subscription

Pursuant to the CIG Subscription Agreement, CIG has been issued 35,057,991 CIG First Tranche Shares and has conditionally subscribed for a further 142,522,475 CIG Second Tranche Shares, subject to, inter alia, shareholder approval. Assuming shareholder approval is received, CIG will be interested in a total of 334,665,274 Ordinary Shares and, dependent on the level of acceptances under the Open Offer, will have a holding of between 40.2 per cent. and 42.0 per cent. in the Enlarged Share Capital.

The terms of the CIG Subscription Agreement include:

· An undertaking by CIG that it will not (save in limited circumstances) dispose of the CIG First Tranche Shares for a period of 12 months from the date of their admission to trading on AIM or the CIG Second Tranche Shares for 12 months from the date of Admission; and

· The grant to CIG of a pre-emption right in relation to further equity issued by the Company while it holds 20 per cent. or more of the Ordinary Shares.

As noted in the Company's 7 February 2023 announcement, CIG is party to a relationship agreement with the Company and the Company's nominated adviser, Strand Hanson Limited, which imposes certain obligations on CIG in its position as a substantial shareholder (as defined under the AIM Rules) in the Company to ensure that the Company will at all times be capable of carrying on its business independently of CIG and the members of its group. The relationship agreement remains in force for so long as CIG's holding remains at 10 per cent. or above of the Company's issued share capital. Under the terms of the CIG Subscription Agreement, CIG has also agreed not to make an offer for the Company without the recommendation of the Board, for so long as its holding is at 15 per cent. or more of the Company's issued share capital, subject to limited exceptions.

CIG intends to finance the CIG Subscription through internal cash resources.

Rule 9 Panel Waiver

The Company requires a waiver granted by the Takeover Panel, pursuant to Rule 9 of the Takeover Code. The Company will also require Independent Shareholder approval to permit the issue of the CIG Second Tranche Shares, which would, if such new Ordinary Shares were issued, result in an increase in CIG's shareholdings to more than 30 per cent. and trigger a mandatory offer to Shareholders under Rule 9. Full details of the Rule 9 Panel Waiver are set out in Part 5 of this document.

Subscription

Certain investors have agreed to subscribe directly with the Company for the Subscription Shares at the Issue Price pursuant to subscription letters entered into individually with the respective Subscribers and the Company. The First Tranche Subscription Shares were issued at the same time as the CIG First Tranche Shares, and it is expected, subject to Shareholder approval, that the Second Tranche Subscription Shares will be issued at the same time as the CIG Second Tranche Shares.

Details Of the Open Offer

Open Offer Entitlement

In recognition of their continued support to the Company, the Company considers it important that, where reasonably practicable, Shareholders have an opportunity to participate in its equity placements.

The Company is providing all Qualifying Shareholders with the opportunity to subscribe, at the Issue Price, for an aggregate maximum of 35,515,679 Open Offer Shares, raising gross proceeds of up to £4 million.

Qualifying Shareholders may apply for Open Offer Shares under the Open Offer at the Issue Price on the following basis:

1 Open Offer Share for every 12.525 Existing Ordinary Shares

held by them and in their names rounded down to the nearest whole number of Ordinary Shares and in proportion for any number of Existing Ordinary Shares held on the Record Date up to their Open Offer Entitlement. Fractional entitlements which would otherwise arise will not be issued to the Qualifying Shareholders but will be made available under the Excess Application Facility.

For the avoidance of doubt, "Qualifying Shareholders" excludes CIG and the subscriber pursuant to the First Tranche Subscription.

Excess Entitlements

The Excess Application Facility enables Qualifying Shareholders to apply for Excess Shares in excess of their Open Offer Entitlement. Not all Shareholders will be Qualifying Shareholders. Shareholders who are located in, or are citizens of, or have a registered office in certain overseas jurisdictions will not qualify to participate in the Open Offer. The attention of Overseas Shareholders is drawn to the section entitled "Overseas Shareholders" below.

Valid applications by Qualifying Shareholders will be satisfied in full up to their Open Offer Entitlements. Qualifying Shareholders can apply for less or more than their Open Offer Entitlements but the Company cannot guarantee that any application for Excess Shares under the Excess Application Facility will be satisfied as this will depend in part on the extent to which other Qualifying Shareholders apply for less than or more than their own Open Offer Entitlements. The Company may satisfy valid applications for Excess Shares in whole or in part but reserves the right at its sole discretion not to satisfy, or to scale back, applications made in excess of Open Offer Entitlements.

Qualifying Shareholders should note that the Open Offer is not a rights issue and therefore the Open Offer Shares which are not applied for by Qualifying Shareholders will not be sold in the market for the benefit of the Qualifying Shareholders who do not apply under the Open Offer. The Application Form is not a document of title and cannot be traded or otherwise transferred.

Application has been made for the Open Offer Entitlements and Excess CREST Open Offer Entitlements for Qualifying CREST Shareholders to be admitted to CREST. It is expected that the Open Offer Entitlements and the Excess CREST Open Offer Entitlements will be admitted to CREST as soon as reasonably practicable after at 8.00 a.m. on 11 January 2024. Applications through the CREST system may only be made by the Qualifying Shareholder originally entitled or by a person entitled by virtue of a bona fide market claim.

The Open Offer Shares must be paid in full on application. The latest time and date for receipt of completed Application Forms or CREST applications and payment in respect of the Open Offer is 11.00 a.m. on 9 January 2024.

Further details of the Open Offer and the terms and conditions on which it is being made, including the procedure for application and payment, are contained in Part 3 of this document and on the accompanying Application Form. The Open Offer is conditional on, inter alia, completion of the Second Tranche Subscription and the CIG Second Tranche Subscription.

Overseas Shareholders

The attention of Qualifying Shareholders who have registered addresses outside the United Kingdom, or who are citizens or residents of countries other than the United Kingdom, or who are holding Existing Ordinary Shares for the benefit of such persons, (including, without limitation, custodians, nominees, trustees and agents) or who have a contractual or other legal obligation to forward this document or the Application Form to such persons, is drawn to the information which appears in paragraph 6 of Part 3 of this document.

In particular, Qualifying Shareholders who have registered addresses in or who are resident in, or who are citizens of, countries other than the UK (including without limitation the United States of America and Canada), should consult their professional advisers as to whether they require any governmental or other consents or need to observe any other formalities to enable them to take up their entitlements under the Open Offer.

General Meeting

The Notice of General Meeting is set out in Part 9 of this document. 

CIG Resolutions

The CIG Resolutions which are required in order to enable the Company to issue and allot the CIG Second Tranche Shares and are summarised below.

Resolution 1

Resolution 1, if passed will grant to the Directors a general authority to allot the CIG Second Tranche Shares and will be proposed as an ordinary resolution. To be passed an ordinary resolution requires a simple majority of the votes cast at the General Meeting (by Shareholders present in person or by proxy) to be cast in its favour.

This authority, if granted by Shareholders, will expire on the date falling 6 calendar months from the date of the passing of the Resolution and will, unless the General Resolutions are passed, be in addition to the 2023 Authorities.

Resolution 1 is conditional on Resolution 2 and the Rule 9 Waiver Resolution being passed at the General Meeting

Resolution 2

Resolution 2, if passed will grant to the Directors the authority to allot the CIG Second Tranche Shares on a non pre-emptive basis and will be proposed as a special resolution. To be passed a special resolution requires at least three quarters of the votes cast at the General Meeting (by Shareholders present in person or by proxy) to be cast in favour of it.

This authority, if granted by Shareholders, will expire on the date falling 6 calendar months from the date of the passing of the Resolution and will, unless the General Resolutions are passed, be in addition to the 2023 Authorities.

Resolution 2 is conditional on Resolution 1 and the Rule 9 Waiver Resolution being passed at the General Meeting

In the event that the CIG Resolutions and the Rule 9 Resolution are not passed at the General Meeting:

a) the CIG Second Tranche Subscription will not complete;

b) the Second Tranche Subscription will not complete; and

c) the Open Offer will not complete.

Subscriptions Resolutions

Resolution 3

Resolution 3, if passed will grant to the Directors a general authority to allot the Second Tranche Subscription Shares and will be proposed as an ordinary resolution. To be passed an ordinary resolution requires a simple majority of the votes cast at the General Meeting (by Shareholders present in person or by proxy) to be cast in its favour.

This authority, if granted by Shareholders, will expire on the date falling 6 calendar months from the date of the passing of the Resolution and will, unless the General Resolutions are passed, be in addition to the 2023 Authorities and the authority granted by Resolution 1.

Resolution 4

Resolution 4, if passed will grant to the Directors a authority to allot the Second Tranche Subscription Shares on a non pre-emptive basis and will be proposed as a special resolution. To be passed a special resolution requires at least three quarters of the votes cast at the General Meeting (by Shareholders present in person or by proxy) to be cast in favour of it.

This authority, if granted by Shareholders, will expire on the date falling 6 calendar months from the date of the passing of the Resolution and will, unless the General Resolutions are passed, be in addition to the 2023 Authorities and the authority granted by Resolution 2.

The Subscription Resolutions are conditional on the passing of the CIG Resolutions and the Rule 9 Waiver Resolution. In the event that the Subscription Resolutions are not passed at the General Meeting, the Second Tranche Subscription will not complete.

Open Offer Resolutions

Resolution 5

Resolution 5, if passed will grant to the Directors a general authority to allot the Open Offer Shares and will be proposed as an ordinary resolution. To be passed an ordinary resolution requires a simple majority of the votes cast at the General Meeting (by Shareholders present in person or by proxy) to be cast in its favour.

This authority, if granted by Shareholders, will expire on the date falling 6 calendar months from the date of the passing of the Resolution and will, unless the General Resolutions are passed, be in addition to the 2023 Authorities and the authority granted by Resolution 1 and 3.

Resolution 6

Resolution 6, if passed will grant to the Directors an authority to allot the Open Offer Shares on a non pre-emptive basis and will be proposed as a special resolution. To be passed a special resolution requires at least three quarters of the votes cast at the General Meeting (by Shareholders present in person or by proxy) to be cast in favour of it.

This authority, if granted by Shareholders, will expire on the date falling 6 calendar months from the date of the passing of the Resolution and will, unless the General Resolutions are passed, be in addition to the 2023 Authorities and the authority granted by Resolution 2 and 4.

The Open Offer Resolutions are conditional on the CIG Resolutions and the Rule 9 Waiver Resolution. In the event that the Open Offer Resolutions are not passed at the General Meeting, the Open Offer will not complete.

General Resolutions

In addition, at the General Meeting the General Resolutions will be proposed to refresh and replace the 2023 Authorities and are summarised below.

Resolution 7

Resolution 7, if passed, will grant to the Directors a general authority to allot:

a) in relation to a pre-emptive rights issue only, equity securities (as defined by section 560 of the Act) up to a maximum nominal amount of £5,550,141, which represents approximately two thirds of the Enlarged Share Capital (assuming the full take up of the Open Offer). This maximum is reduced by the nominal amount of any Relevant Securities allotted under paragraph (b) below;

b) in any other case, Relevant Securities up to a maximum nominal amount of £2,775,071 which represents approximately one third of the Enlarged Share Capital (assuming the full take up of the Open Offer). This maximum is reduced by the nominal amount of any equity securities allotted under paragraph (a) above in excess of £2,775,070.

Therefore, the maximum nominal amount of Relevant Securities (including equity securities) which may be allotted under this resolution is £5,550,141. Resolution 7 will be proposed as an ordinary resolution. To be passed an ordinary resolution requires a simple majority of the votes cast at the General Meeting (by Shareholders present in person or by proxy) to be cast in its favour.

This authority, if granted by Shareholders, will expire on the date which is 18 months after the date on which it is passed or, if earlier, the date of the next annual general meeting of the Company and will, be in substitution for 2023 Authorities, but will be in addition to the authority granted by Resolutions 1, 3 and 5.

The Directors currently intend only to make use of this authority:

a) in connection with the grant of any options to the directors of the Company and employees of the Company's group; and

b) as may be necessary to manage the Company's capital resources.

Resolution 7 is conditional on the passing of the CIG Resolutions, the Subscription Resolutions and the Rule 9 Waiver Resolution.

Resolution 8

Resolution 8, if passed, will give the Directors power, pursuant to the authority to allot granted by Resolution 7 to allot equity securities (as defined by section 560 of the Act) or sell treasury shares for cash without first offering them to existing shareholders in proportion to their existing holdings up to a maximum nominal amount of £832,521 which represents approximately 10 per cent. of the Enlarged Share Capital (assuming the full take up of the Open Offer).

Resolution 8 will be proposed as a special resolution. To be passed a special resolution requires at least three quarters of the votes cast at the General Meeting (by Shareholders present in person or by proxy) to be cast in favour of it.

The directors have no immediate plans to make use of this authority other than in those circumstances which are referred to in the explanation relating to Resolution 7.

This authority, if granted by Shareholders, will expire and will expire on the date which is 18 months after the date on which it is passed or, if earlier, the date of the next annual general meeting of the Company and will, be in substitution for 2023 Authorities, but will be in addition to the authority granted by Resolutions 2, 4 and 6.

Resolution 8 is conditional on the passing of the CIG Resolutions, the Subscription Resolutions, the Rule 9 Waiver Resolution and Resolution 7.

Resolution 9

Resolution 9 is the Rule 9 Waiver Resolution and will be proposed as an ordinary resolution for of Independent Shareholders to approve the Rule 9 Panel Waiver. If passed it will approve the Rule 9 Panel Waiver and (subject to the passing of the CIG Resolutions) will allow the issue of the CIG Second Tranche Shares to CIG without CIG being required to make a mandatory offer under Rule 9.

Irrevocable Undertakings and Recommendation

The Directors consider the issue of the Second Tranche Subscription Shares, the CIG Second Tranche Shares and the Open Offer Shares to be fair and reasonable and in the best interests of the Company as a whole and accordingly unanimously recommend that Shareholders vote in favour of Resolutions 1 to 8 in this regard.

The Independent Directors, who have been so advised by Strand Hanson Limited, consider the Proposals set out in this document to be fair and reasonable and in the best interests of the Company and its Independent Shareholders as a whole, including in respect of the intentions of CIG in respect of the ongoing strategy and operation of the Group, as set out in paragraph 4 of Part 7 of this document. In providing advice to the Independent Directors, Strand Hanson Limited has taken into account the commercial assessment of the Independent Directors.

Accordingly, the Independent Directors unanimously recommend that Independent Shareholders vote in favour of the Rule 9 Waiver Resolution (which is to be proposed as Resolution 9), as the Independent Directors intend to do in respect of their own beneficial holdings.

Stephen Betts, Dan Betts and Tom Hill (being the only Directors holding Ordinary Shares as at the Last Practicable Date) and CIG, holding, in aggregate, between them approximately 31.4 per cent. of the Existing Ordinary Shares, have undertaken to vote in favour of the Resolutions in respect of their respective holdings of Ordinary Shares in the Company. For the avoidance of doubt, CIG is not able to vote in respect of Resolution 9.

In addition, certain shareholders, holding, in aggregate, between them approximately 2.00 per cent. of the Existing Ordinary Shares, have indicated, without having signed an undertaking, that they intend to vote in favour of the Resolutions.

The CIG Second Tranche Subscription is conditional on the passing of the CIG Resolutions and the Rule 9 Waiver Resolution. The Second Tranche Subscription is conditional on the passing of the CIG Resolutions, Rule 9 Waiver Resolution and the Subscription Resolutions. The Open Offer is conditional on the passing of the CIG Resolutions, the Rule 9 Waiver Resolution and the Open Offer Resolutions.

Extract from the Circular - Definitions

The following definitions apply throughout this document unless the context otherwise requires:

2023 AGM

the last annual general meeting of the Company held on 29 June 2023

2023 Authorities

the shareholder authorities granted by resolutions 4 and 5 as set out in the notice of the 2023 AGM

Act

the Companies Act 2006 (as amended)

acting in concert

has the meaning attributed to it in the Takeover Code

Admission

admission to trading on AIM of the New Ordinary Shares becoming effective in accordance with the AIM Rules

AIM

the AIM market operated by the London Stock Exchange

AIM Rules

the AIM Rules for Companies published by the London Stock Exchange from time to time

Application Form

the application form enclosed with this document on which Qualifying Non-CREST Shareholders may apply for Open Offer Shares under the Open Offer

Articles

the articles of association of the Company as at the date of this document

Board or Directors

the board of directors of the Company from time to time

borrowed or lent

in the context of the Takeover Code, includes for these purposes any financial collateral arrangement of the kind referred to in Note 4 on Rule 4.6 of the Takeover Code, but excludes any borrowed shares which have either been on-lent or sold

certificated or in certificated form

an Ordinary Share recorded on the Company's share register as being held in certificated form (namely, not in CREST)

Chairman

the Chairman of the Board from time to time

CIG

CIG SA, an investment company registered in the Trade and Personal Property Credit Register of Burkina Faso with registered number BF OUA 2019 B 2606, and which is controlled by the same principal as the Company's primary lending bank

CIG Announcement

RNS Number 0128W released by the Company on 7 December 2023 relating to, inter alia, the CIG Subscription

CIG First Tranche Shares

35,057,991 of the CIG Subscription Shares

CIG First Tranche Subscription

the unconditional subscription for the CIG First Tranche Shares at the Issue Price

CIG Resolutions

those Resolutions numbered 1 and 2 in the Notice of General Meeting

CIG Second Tranche Shares

142,522,475 of the CIG Subscription Shares

CIG Second Tranche Subscription

the conditional subscription for the CIG Second Tranche Shares at the Issue Price

CIG Subscription

the subscription by CIG for the CIG Subscription Shares at the Issue Price pursuant to the CIG Subscription Agreement

CIG Subscription Agreement

the agreement dated 6 December 2023 between the Company (1) and CIG (2) in respect of the CIG Subscription

CIG Subscription Shares

 177,580,466 new Ordinary Shares

Company

Hummingbird Resources plc, a company registered in England and Wales with Company number 05467327

connected persons

in the context of the Takeover Code, means in relation to a Director, those persons whose interests in Ordinary Shares the Director would be required to disclose pursuant to Part 22 of the Companies Act 2006 and related regulations and includes any spouse, civil partner, infants (including step children), relevant trusts and any company in which a director holds at least 20 per cent. of its voting capital

Coris Bank

Coris Bank International (Burkina Faso)

Coris Holdings

Coris Holdings SA, a 63.61 per cent. shareholder in Coris Bank

CREST

the relevant system (as defined in the CREST Regulations) in respect of which Euroclear is the operator (as defined in those regulations)

CREST Manual

the rules governing the operation of CREST, as published by Euroclear

CREST member

a person who has been admitted by Euroclear as a system-member (as defined in the CREST Regulations)

CREST participant

a person who is, in relation to CREST, a system participant (as defined in the CREST Regulations)

CREST member account ID

the identification code or number attached to a member account in CREST

CREST participant ID

shall have the meaning given in the CREST Manual

CREST payment

shall have the meaning given in the CREST Manual

CREST Regulations

the Uncertificated Securities Regulations 2001 (S.I. 2001 No, 3755) (as amended)

CREST sponsor

a CREST participant admitted to CREST as a CREST sponsor

CREST sponsored member

a CREST member admitted to CREST as a sponsored member (which includes all CREST Personal Members)

dealing or dealt

in the context of the Takeover Code, includes:

(a) acquiring or disposing of relevant securities, of the right (whether conditional or absolute) to exercise or direct the exercise of the voting rights attaching to relevant securities, or of general control of relevant securities;

(b) taking, granting, acquiring, disposing of, entering into, closing out, terminating, exercising (by either party) or varying an option (including a traded option contract) in respect of any relevant securities;

(c) subscribing or agreeing to subscribe for relevant securities;

(d) exercising or converting, whether in respect of new or existing relevant securities, any securities carrying conversion or subscription rights;

(e) acquiring, disposing of, entering into, closing out, exercising (by either party) of any rights under, or varying, a derivative referenced, directly or indirectly, to securities;

(f) entering into, terminating or varying the terms of any agreement to purchase or sell securities;

(g) redeeming or purchasing, or taking or exercising an option over, any of its own relevant securities by the offeree company or an offeror; and

(h) any other action resulting, or which may result, in an increase or decrease in the number of relevant securities in which a person is interested or in respect of which he has a short position

derivatives

include any financial product whose value in whole or in part is determined directly or indirectly by reference to the price of an underlying security

Enlarged Share Capital

the 832,521,218 Ordinary Shares in issue following the issue allotment and admission to trading of the New Ordinary Shares, assuming full subscription for the Open Offer Shares

Euroclear

Euroclear UK & International Limited, the operator of CREST

Excess Application Facility

the arrangement pursuant to which Qualifying Shareholders may apply for additional Open Offer Shares in excess of their Open Offer Entitlement in accordance with the terms and conditions of the Open Offer

Excess CREST Open Offer Entitlement

in respect of each Qualifying CREST Shareholder, their entitlement (in addition to their Open Offer Entitlement) to apply for Open Offer Shares pursuant to the Excess Application Facility, which is conditional on them taking up their Open Offer Entitlement in full

Excess Entitlement

Open Offer Shares in excess of the basic Open Offer Entitlement (but not in excess of the total number of Open Offer Shares)

Excess Shares

Ordinary Shares applied for by Qualifying Shareholders under the Excess Application Facility

Ex-entitlement Date

the date on which the Existing Ordinary Shares are marked "ex" for entitlement under the Open Offer, being 8.00 a.m. on 21 December 2024

Existing Ordinary Shares

640,495,504 Ordinary Shares in issue as at the date of this document

FCA

the Financial Conduct Authority

Financial Promotion Order

the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended)

First Tranche Subscription

the unconditional subscription for the First Tranche Subscription Shares

First Tranche Subscription Shares

3,518,814 of the Subscription Shares

Form of Proxy

the form of proxy for use in connection with the General Meeting

FSMA

the Financial Services and Markets Act 2000 (as amended)

General Meeting  

the general meeting of the Company to be held at the offices of Gowling WLG (UK) LLP at 4 More London Riverside, London SE1 2AN at 1:00 p.m. on 10 January 2024, or any adjournment thereof, notice of which is set out at the end of this document

General Resolutions

those Resolutions numbered 7 and 8 in the Notice of General Meeting

Group

together the Company and its subsidiary undertakings

Independent Directors

all of the Directors, with the exception of Ernie Nutter, who is participating in the Second Tranche Subscription

Independent Shareholders

all of the Shareholders, with the exception of CIG

interest

in the context of the Takeover Code, a person having an interest in relevant securities includes where a person

(a) owns securities;

(b) has the right (whether conditional or absolute) to exercise or direct the exercise of the voting rights attaching to securities or has general control of them;

(c) by virtue of any agreement to purchase, option or derivative, has the right or option to acquire securities or call for their delivery or is under an obligation to take delivery of them, whether the right, option or obligation is conditional or absolute and whether it is in the money or otherwise; or

(d) is party to any derivative whose value is determined by reference to the prices of securities and which results, or may result, in his having a long position in them

Irrevocable Undertakings

the irrevocable undertaking from CIG and each of the Directors as described in paragraph 6.1 of Part 6

ISIN

International Securities Identification Number

Issue Price

11.2625 pence per New Ordinary Share

Latest Practicable Date

20 December 2023 being the latest practicable date prior to the publication of this document

London Stock Exchange

London Stock Exchange plc

New Ordinary Shares

the Second Tranche Subscription Shares, the CIG Second Tranche Shares and the Open Offer Shares

Notice of General Meeting

the notice of the General Meeting set out at the end of this document

Open Offer

the conditional invitation made to Qualifying Shareholders to apply to subscribe for Open Offer Shares at the Issue Price on the terms and subject to the conditions set out in Part 3 (Terms and Conditions of the Open Offer) of this document and, where relevant, in the Application Form

Open Offer Entitlement

the pro rata entitlement of a Qualifying Shareholder, pursuant to the Open Offer, to subscribe for 1 Open Offer Share for every 12.525 Existing Ordinary Shares registered in their name as at the Record Date

Open Offer Shares

up to 35,515,679 new Ordinary Shares conditionally offered to Qualifying Shareholders pursuant to the Open Offer

Official List

the Official List of the FCA

Ordinary Shares

ordinary shares of £0.01 each in the capital of the Company

Overseas Shareholders

Shareholders with registered addresses, or who are citizens or residents of, or incorporated in, countries outside of the United Kingdom

Placement

together the Subscription and the CIG Subscription (but, for the avoidance of doubt, excluding the Open Offer)

Qualifying CREST Shareholders

Qualifying Shareholders holding Existing Ordinary Shares in a CREST account

Qualifying Non-CREST Shareholders

Qualifying Shareholders holding Existing Ordinary Shares in certificated form

Qualifying Shareholders

subject to any restrictions imposed on Overseas Shareholders, holders of Existing Ordinary Shares whose names appear on the register of members of the Company on the Record Date as holders of Existing Ordinary Shares and who are eligible to be offered Open Offer Shares under the Open Offer in accordance with the terms and conditions set out in this document and the Application Form and for the avoidance of doubt the Open Offer is not being made to (i) persons in Restricted Jurisdictions; or (ii) CIG; or (iii) any subscribers under the First Tranche Subscription.

Proposals

the proposals being the issue of the Second Tranche Subscription Shares, the CIG Second Tranche Shares and the Open Offer Shares

 

Prospectus Rules

the prospectus rules published by the FCA pursuant to section 73A of FSMA (as amended from time to time)

Prospectus Regulation

EU Regulation 2017/1129 (which forms part of UK domestic law pursuant to the European Union (Withdrawal) Act 2018) on the requirements for a prospectus to be published when securities are offered to the public or admitted to trading

Receiving Agents

Link Group, Corporate Actions, Central Square, 29 Wellington Street, Leeds LS1 4DL

Record Date

6.00 p.m. on 19 December 2023, being the record date for the purposes of the Open Offer

Registrars

Link Group, Central Square, 29 Wellington Street, Leeds LS1 4DL

Relevant Securities

(a) shares in the Company other than shares allotted pursuant to:

 

(i) an employee share scheme (as defined by section 1166 of the Act); or

 

(ii) a right to subscribe for shares in the Company where the grant of the right itself constituted a Relevant Security; or

 

(iii) a right to convert securities into shares in the Company where the grant of the right itself constituted a Relevant Security.

 

(b) any right to subscribe for or to convert any security into shares in the Company other than rights to subscribe for or convert any security into shares allotted pursuant to an employee share scheme (as defined by section 1166 of the Act). References to the allotment of Relevant Securities include the grant of such rights.

Resolutions

the resolutions set out in the Notice of General Meeting

Restricted Jurisdictions

the United States of America, Australia, Canada, Japan, the Republic of South Africa and any other jurisdiction where the extension or availability of the Open Offer would breach any applicable law

Rule 9

Rule 9 of the Takeover Code

Rule 9 Panel Waiver

the waiver granted by the Takeover Panel, subject to approval of the Independent Shareholders, of the obligation on CIG to make a mandatory offer to Shareholders for the Ordinary Shares not owned by CIG upon completion of the issue of the CIG Second Tranche Shares which would otherwise arise under Rule 9

Rule 9 Waiver Resolution

Resolution 9 as set out in the Notice of General Meeting

Second Tranche Subscription Shares

13,987,560 of the Subscription Shares

Second Tranche Subscription

the conditional subscription by subscribers other than CIG for the Second Tranche Subscription Shares at the Issue Price

Shareholders

holders of Ordinary Shares

short position

in the context of the Takeover Code, means any short position (whether conditional or absolute and whether in the money or otherwise) including any short position under a derivative, any agreement to sell or any delivery obligation or right to require another person to purchase or take delivery

Subscription

the direct subscription with the Company by certain subscribers, other than CIG, for the Subscription Shares at the Issue Price

Subscription Shares

together the First Tranche Subscription Shares and the Second Subscription Shares

uncertificated or uncertificated form

recorded on a register of securities maintained by Euroclear in accordance with the CREST Regulations as being in uncertificated form in CREST and title to which, by virtue of the CREST Regulations, may be transferred by means of CREST

Takeover Code

the City Code on Takeovers and Mergers

Takeover Panel

the Panel on Takeovers and Mergers

UK or United Kingdom

the United Kingdom of England, Scotland, Wales and Northern Ireland

US or United States

the United States of America, its territories and possessions, any state of the United States of America and the District of Columbia

US Securities Act

the US Securities Act of 1933 (as amended)

VWAP

volume weighted average price

£ and p and GBP and pence

the legal tender of the United Kingdom from time to time

US$ or $

US dollars being the legal tender of the United States from time to time

Voting Record Time

the time and date on which Shareholders must be on the Company's register of members in order to be able to attend and vote at the General Meeting, being 6.00 p.m. on 09 January 2024

 

 

Extract from the Circular - Statistics of the Placement and Open Offer

Issue Price

11.2625 pence

Number of Existing Ordinary Shares in issue as at the date of this document

640,495,504

Percentage of Existing Ordinary Shares held by CIG as at the Latest Practicable Date

29.999 per cent.

Number of Second Tranche Subscription Shares**

13,987,560

Number of CIG Second Tranche Shares**

142,522,475

Maximum number of Open Offer Shares being offered pursuant to the Open Offer**

35,515,679

Number of New Ordinary Shares*

192,025,714

Enlarged Share Capital*

832,521,218

Market capitalisation of the Enlarged Share Capital at the Issue Price*

c. £93.8 million

Maximum percentage of the Enlarged Share Capital represented by the CIG Subscription Shares***

 42.0 per cent.

Percentage of the Enlarged Share Capital represented by the New Ordinary Shares**

23.1 per cent.

Maximum proceeds of the Open Offer*

c. £4,000,000

Estimated gross proceeds of the Placement (inclusive of the proceeds of the First Tranche Subscription and the CIG First Tranche Subscription, but exclusive of any funds raised pursuant to the Open Offer)

c. $27,684,000

ISIN of the Existing Ordinary Shares

GB00B60BWY28

ISIN of the Open Offer Shares: Open Offer Entitlement

GB00BP2F2566

ISIN of the Open Offer Shares: Excess CREST Open Offer Entitlement

GB00BP2F2673

Assuming that the Open Offer is fully subscribed

**  Assuming that the Resolutions are passed at the General Meeting

***  Assuming that the Resolutions are passed at the General Meeting and there is no uptake under the Open Offer

The exchange rate used throughout this document for converting US dollars to pounds sterling is 0.7937

Extract from the Circular - Expected Timetable of Principal Events

Each of the times and dates in the below is indicative only and may be subject to change by the Company, in which event details of the new times and dates will be notified to shareholders by announcement through a Regulatory Information Service.

Record Date for entitlements under the Open Offer

6:00 p.m. on 19 December 2023

Voting Record Date for attendance and voting at the General Meeting

6:00 p.m. on 9 January 2024

Publication of this Circular and (to Qualifying Non-CREST Shareholders only) the Application Form

21 December 2023

Ex-entitlement Date for the Open Offer

8:00 a.m. on 21 December 2023

Open Offer Entitlements and Excess CREST Open Offer Entitlements credited to stock accounts of Qualifying CREST Shareholders in CREST

As soon as practical after 8:00 pm on 22 December 2023

Latest recommended time and date for requesting withdrawal of Open Offer Entitlements and Excess CREST Open Offer Entitlements from CREST

4:30 p.m. on 3 January 2024

Latest time and date for depositing Open Offer Entitlements and Excess CREST Open Offer Entitlements into CREST

3.00 p.m. on 4 January 2024

Latest time and date for splitting Application Forms (to satisfy bona fide market claims only)

3.00 p.m. on 5 January 2024

Latest time and date for receipt of completed Forms of Proxy and receipt of electronic proxy appointments via the CREST system

1.00 p.m. on 8 January 2024

Latest time and date for receipt of the completed Application Form and appropriate payment in respect of Open Offer Shares or settlement of relevant CREST instruction

11.00 a.m. on 9 January 2024

Announcement of result of Open Offer

10 January 2024

General Meeting

1.00 p.m. on 10 January 2024

Announcement of results of General Meeting

10 January 2024

Admission and commencement of dealings in the New Ordinary Shares on AIM

from 8:00 a.m. on 11 January 2024

CREST accounts expected to be credited for the New Ordinary Shares

from 8:00 a.m. on 11 January 2024

Latest date for posting of share certificates for the New Ordinary Shares in certificated form (if applicable)

by 18 January 2024

Certain of the events in the above timetable are conditional upon, inter alia, the approval of the Resolutions to be proposed at the General Meeting.

All references to time and dates in this document are to time and dates in London.

**ENDS**

Notes to Editors:

Hummingbird Resources plc (AIM: HUM) is a leading multi-asset, multi-jurisdiction gold producing Company, member of the World Gold Council and founding member of Single Mine Origin (www.singlemineorigin.com). The Company currently has two core gold projects, the operational Yanfolila Gold Mine in Mali, and the Kouroussa Gold Mine in Guinea, which will more than double current gold production once at commercial production. Further, the Company has a controlling interest in the Dugbe Gold Project in Liberia that is being developed by joint venture partners, Pasofino Gold Limited. The final feasibility results on Dugbe showcase 2.76Moz in Reserves and strong economics such as a 3.5-year capex payback period once in production, and a 14-year life of mine at a low AISC profile. Our vision is to continue to grow our asset base, producing profitable ounces, while central to all we do being our Environmental, Social & Governance ("ESG") policies and practices.

 

For further information, please visit hummingbirdresources.co.uk or contact:

 

·

Daniel Betts, CEO

Thomas Hill, FD

Edward Montgomery, CD

Hummingbird Resources plc

Tel: +44 (0) 20 7409 6660

James Spinney

Ritchie Balmer

Strand Hanson Limited

Nominated Adviser

Tel: +44 (0) 20 7409 3494

James Asensio

 

Canaccord Genuity Limited

Broker

Tel: +44 (0) 20 7523 8000

Bobby Morse

Oonagh Reidy

George Pope

Buchanan

Financial PR/IR

Tel: +44 (0) 20 7466 5000

Email: HUM@buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAKAFASSDFEA
Date   Source Headline
25th Apr 20247:00 amRNSQ1 2024 Operational and Trading Update
19th Apr 20247:00 amRNSNotice of Q1-2024 Operational and Trading Update
16th Apr 20247:00 amRNSOperation Update & Kouroussa Production Roadmap
28th Mar 20247:00 amRNSUpdate of Mining Operations at Kouroussa
20th Mar 20243:26 pmRNSResponse to Corica Mining Statement
18th Mar 20249:32 amRNSUpdate on Mining Operations at Kouroussa
11th Mar 20248:00 amRNSBlock Listing Six Monthly Return
27th Feb 20247:00 amRNSPasofino Gold announces exploration update
5th Feb 20248:00 amRNSUpdated Corporate Presentation
31st Jan 20247:00 amRNSQ4-2023 Operational and Trading Update
25th Jan 20247:00 amRNSKouroussa Mine Update/Notice of Q4 Trading Update
24th Jan 20247:00 amRNSPasofino Gold Announces US$2.3m Private Placement
19th Jan 202412:47 pmRNSNotification of Major Holdings
10th Jan 20242:21 pmRNSResult of GM, Director Dealing and TVR
10th Jan 20247:00 amRNSResult of Open Offer and Director Dealing
21st Dec 20237:00 amRNSPlacement Update, Open Offer & Notice of GM
21st Dec 20237:00 amRNSOperational and Exploration Update
13th Dec 20237:00 amRNSCompletion of Pasofino Gold to 51% interest
7th Dec 20237:00 amRNSCorporate strategy update, equity placement & TVR
16th Nov 20237:00 amRNSUpdated Corporate Presentation
26th Oct 20237:00 amRNSQ3-2023 Operational and Trading Update
19th Oct 20237:00 amRNSNotice of Q3-2023 Operational and Trading Update
10th Oct 20237:00 amRNSUpdate Interview with Senior Management
28th Sep 20237:00 amRNS1H23 Group Interim Results
13th Sep 20237:00 amRNS2023 Updated Reserves and Resources Statements
11th Sep 20237:00 amRNSBlock Listing Six Monthly Return
25th Jul 20237:30 amRNSQ2 2023 Operational Trading Update Presentation
25th Jul 20237:00 amRNSQ2 2023 Operational and Trading Update
13th Jul 20237:00 amRNSNotice of Second Quarter Trading Update
29th Jun 202310:12 amRNSResult of AGM
29th Jun 20237:00 amRNS2023 AGM Statement
9th Jun 20237:00 amRNSFirst Gold Pour at Kouroussa Gold Mine
6th Jun 20237:00 amRNSPublication of Annual Report
6th Jun 20237:00 amRNSPublication of Sustainability Report 2022
5th Jun 20237:00 amRNSUpdated Corporate Presentation
22nd May 20237:00 amRNSKouroussa Gold Mine Commissioning Update
2nd May 20237:00 amRNSKouroussa Gold Mine Commissioning Begins
19th Apr 20237:30 amRNSMedia presentation of Q1 2023 Operational Update
19th Apr 20237:00 amRNSQ1 2023 Operational and Trading Update
18th Apr 202311:37 amRNSAIM Rule 17
31st Mar 20237:00 amRNS2023 LTIP & Deferred Share Awards and TVR
20th Mar 20239:05 amRNSSecond Price Monitoring Extn
20th Mar 20239:00 amRNSPrice Monitoring Extension
13th Mar 20232:54 pmRNSResult of General Meeting, Director Dealing & TVR
10th Mar 20237:30 amRNSKouroussa Gold Mine, Construction Media Update
10th Mar 20237:05 amRNSBlock Listing Six Monthly Return
10th Mar 20237:00 amRNSResult of Open Offer and Director Dealing
7th Mar 20232:05 pmRNSSecond Price Monitoring Extn
7th Mar 20232:00 pmRNSPrice Monitoring Extension
2nd Mar 202311:36 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.